⌘K
Loading ticker…
As of 2026-08-24, Ardelyx, Inc. (ARDX) has a 3-month relative strength percentile of 10 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.1%, relative volume 1.07×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ARDX is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -25.4% / -37.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ARDX is held by 22 ETFs as of May 2026. Top owner: VTWO at 0.04% weight, $7M notional. Top 3 carry $19M.
Held by 46 ETFs · $195M across latest filings · largest weight 1.63% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.04% | $7M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.03% | $7M | — |
| VHTVanguard Health Care ETF | 0.02% | $4M | — |
| VTWG | 0.08% | $1M | −0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $872K |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| — |
| ONEQ | 0.01% | $558K | — |
| ISMD | 0.17% | $548K | −0.03 pp |
| VFMO | 0.03% | $525K | −0.04 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $119K | — |
| OMFS | 0.03% | $99K | −0.02 pp |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARDX Jan avg: 20.31% median: 18.81% win: 100% σ: 18.92% n: 4 2022-04-12 → 2026-07-31 | ARDX Feb avg: -2.44% median: -0.85% win: 25% σ: 9.03% n: 4 2022-04-12 → 2026-07-31 | ARDX Mar avg: 6.93% median: -8.47% win: 25% σ: 40.08% n: 4 2022-04-12 → 2026-07-31 | ARDX Apr avg: -2.20% median: -6.89% win: 40% σ: 10.56% n: 5 2022-04-12 → 2026-07-31 | ARDX May avg: -15.22% median: -20.24% win: 20% σ: 16.33% n: 5 2022-04-12 → 2026-07-31 | ARDX Jun avg: -1.87% median: 1.50% win: 60% σ: 10.49% n: 5 2022-04-12 → 2026-07-31 | ARDX Jul avg: 2.93% median: 8.16% win: 60% σ: 17.76% n: 5 2022-04-12 → 2026-07-31 | ARDX Aug avg: 26.32% median: 23.58% win: 100% σ: 20.05% n: 4 2022-04-12 → 2026-07-31 (current) | ARDX Sep avg: 4.86% median: 3.63% win: 50% σ: 17.19% n: 4 2022-04-12 → 2026-07-31 | ARDX Oct avg: 4.51% median: 3.40% win: 50% σ: 17.57% n: 4 2022-04-12 → 2026-07-31 | ARDX Nov avg: 5.29% median: 5.38% win: 50% σ: 10.56% n: 4 2022-04-12 → 2026-07-31 | ARDX Dec avg: 23.28% median: 19.00% win: 75% σ: 34.96% n: 4 2022-04-12 → 2026-07-31 |